Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
COSTS AND EXPENSES:        
Research and development $ 3,937,464 $ 2,683,944 $ 13,198,294 $ 7,765,673
General and administrative 1,882,190 1,225,993 5,009,581 3,725,153
Total costs and expenses 5,819,654 3,909,937 18,207,875 11,490,826
LOSS FROM OPERATIONS (5,819,654) (3,909,937) (18,207,875) (11,490,826)
OTHER INCOME:        
Interest income, net 590 374 3,611 11,730
Total other income 590 374 3,611 11,730
NET LOSS $ (5,819,064) $ (3,909,563) $ (18,204,264) $ (11,479,096)
Earnings Per Share, Basic $ (0.10) $ (0.15) $ (0.34) $ (0.69)
Earnings Per Share, Diluted $ (0.10) $ (0.15) $ (0.34) $ (0.69)
Weighted Average Number of Shares Outstanding, Basic 59,868,374 26,326,782 53,633,421 16,539,183
Weighted Average Number of Shares Outstanding, Diluted 59,868,374 26,326,782 53,633,421 16,539,183